Similar Articles

Psychedelic Chemicals and Depression Treatment

Ayşe Zağlı, İlknur Altuntaş, Oytun Erbaş

DOI: 10.5606/jebms.2021.75667

Issue: 2021, Volume 2 - Issue 2
925 1222

NLRP3 Inflammasome: A New Target in Psychiatric Disorders

Sevda Çelik, Aylin Kayaaltı, Oytun Erbaş

DOI: 10.5606/jebms.2021.75681

Issue: 2021, Volume 2 - Issue 3
1356 736

Glutamate Receptor Activity in Neuropsychiatric Disorders

Damla Koyun, Merve Nur Sevinç, İlknur Altuntaş, Oytun Erbaş

DOI: 10.5606/jebms.2022.1009

Issue: 2022, Volume 3 - Issue 1
741 523

Understanding the Role of DISC1 in Psychiatric Disorders

Şeyda Yazıcı, Hadi Sasani, Oytun Erbaş

DOI: 10.5606/jebms.2022.1011

Issue: 2022, Volume 3 - Issue 1
936 538

Human Prefrontal Cortex: Regions and Functions

Ece Sarı, Oytun Erbaş

DOI: 10.5606/jebms.2022.1020

Issue: 2022, Volume 3 - Issue 2
1787 828

Evidence for Genetic Relationships in Attention-Deficit Hyperactivity Disorder

Büşra Candan Balkan, Kerem Can Tunç, Oytun Erbaş

DOI: 10.5606/jebms.2022.1036

Issue: 2022, Volume 3 - Issue
548 508

Mental Health Disorders Associated with Bartonella spp. and Toxoplasma gondii

Kerem Can Tunç,Oytun Erbaş

DOI: 10.5606/jebms.2022.1037

Issue: 2022, Volume 3 - Issue
2496 795

Non-Coding RNAs in Brain Function and Disorders

Buse Kaptan, Mai Abusalim, Oytun Erbaş

DOI: 10.5606/jebms.2023.1042

Issue: 2023, Volume 4 - Issue 1
481 493

Endoplasmic Reticulum Stress: Implications for Psychiatric Disorders

Ecren Büyükada, Ejder Saylav Bora, İlknur Altuntaş, Oytun Erbaş

DOI: 10.5606/jebms.2023.1044

Issue: 2023, Volume 4 - Issue 1
692 457